Arvinas Inc (ARVN)
31.60
-0.94
(-2.89%)
USD |
NASDAQ |
Apr 25, 16:00
31.60
0.00 (0.00%)
After-Hours: 20:00
Arvinas Total Liabilities (Quarterly): 644.60M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 644.60M |
| September 30, 2023 | 601.10M |
| June 30, 2023 | 619.90M |
| March 31, 2023 | 664.80M |
| December 31, 2022 | 703.90M |
| September 30, 2022 | 713.30M |
| June 30, 2022 | 736.40M |
| March 31, 2022 | 765.00M |
| December 31, 2021 | 799.90M |
| September 30, 2021 | 787.13M |
| June 30, 2021 | 61.08M |
| March 31, 2021 | 66.47M |
| Date | Value |
|---|---|
| December 31, 2020 | 75.20M |
| September 30, 2020 | 66.83M |
| June 30, 2020 | 64.80M |
| March 31, 2020 | 70.74M |
| December 31, 2019 | 74.96M |
| September 30, 2019 | 74.93M |
| June 30, 2019 | 55.54M |
| March 31, 2019 | 58.83M |
| December 31, 2018 | 62.61M |
| September 30, 2018 | 62.56M |
| June 30, 2018 | 61.71M |
| December 31, 2017 | 66.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
55.54M
Minimum
Jun 2019
799.90M
Maximum
Dec 2021
402.45M
Average
601.10M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 137.21B |
| Bristol-Myers Squibb Co | 65.67B |
| Janux Therapeutics Inc | 36.06M |
| Geron Corp | 146.13M |
| Verastem Inc | 92.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.305B |
| Shareholders Equity (Quarterly) | 660.00M |
| Debt to Equity Ratio | 0.0012 |
| Current Ratio | 4.979 |
| Net Debt Paydown Yield | 0.00% |